Novo Nordisk's campaign about obesity, particularly in Spain, has ignited debate over the medical and social implications of obesity perception amid rising anti-obesity drugs. The campaign was met with severe backlash on social media for being labeled as fatphobic, which led to concerns from the Spanish Ministry of Health about potential covert advertising. Novo Nordisk defended their message, asserting that obesity is a disease necessitating medical attention, not merely an aesthetic concern. Critics, including activists and nutritionists, argue the campaign pathologizes larger bodies and reflects broader societal tensions regarding body image and health.
The Novo Nordisk campaign aims to create public awareness about obesity as a disease, separating it from aesthetic trends and promoting the importance of visiting a doctor.
Philosopher Magdalena Pineyro calls the campaign's unfiltered talk a response to perceived censorship by activists, reflecting conservative complaints about free speech limits.
Azahara Nieto criticizes the campaign for being populist, claiming it pathologizes larger bodies without acknowledging their health status.
Novo Nordisk faced backlash for its campaign being labeled fatphobic, tasteless, and indecent, prompting intervention from the Spanish Ministry of Health.
Collection
[
|
...
]